Sale

Sinusitis Treatment Market

Global Sinusitis Treatment Market Share, Size, Analysis, Forecast: By Treatment: Analgesics, Antihistamines, Corticosteroids, Antibiotics, Sulphonamides, Quinolones, Surgery, Others; By Disease Type: Acute Sinusitis, Others; By Route of Administration; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Sinusitis Treatment Market Outlook

The global sinusitis treatment market size reached a value of about USD 3.32 billion in 2023. The market is expected to grow at a CAGR of 3.8% during the forecast period of 2024-2032 to attain a value of USD 4.65 billion by 2032, driven by the rising prevalence of increasing pollution and increasing nasal infections among people worldwide.

 

sinusitis treatment market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Sinusitis Treatment Market: Introduction and Insight

When the tissues lining the sinuses gets swollen or inflamed, the condition is called sinusitis. Sinuses are the spaces in the skull that are filled with air. Sinuses can be found behind the nasal bones, forehead, cheeks, and eyes. The problem occurs when these sinuses get blocked due to any reason such as viruses, infections, or mucus. This condition allows the growth of bacteria in sinuses and impact the health of a person suffering from sinusitis. Healthy sinuses have no viruses or germs.

 

Sinusitis may develop due to the conditions that are mentioned below:

  • Tilted nasal septum, where the nose is a bit deviated or tilted in comparison with the usual nose bone. It is not straight in this condition.
  • Allergies and viral or seasonal infections can cause the development of mucus in a higher than rate and amount. This much development of mucus in sinuses can block it and create issues.
  • Tiny hair could also act as an obstacle in the way of mucus trying to run out of the sinus.

 

Sinusitis is a condition which comes with the underlying symptoms. These symptoms are divided into two separate categories as major and minor symptoms. Major symptoms include lack of smelling senses, pressure in the face usually and especially while bending downward or forward, pressure in ear and headaches, having a stuffed or blocked nose and minor symptoms include coughing, exhaustion, fever, bad breath, pain in teeth.

 

Sinusitis can be divided into three categories:

  • Acute Sinusitis: When the symptoms last less than 12 weeks.
  • Chronic Sinusitis: When the symptoms last for more than 12 weeks.
  • Subacute Sinusitis: When the symptoms last for 4 to 12 weeks.

 

Sinusitis can be cured without medicines and it is not always preferred to have a medicated supervision when having sinusitis. Most of the sinusitis does not require exclusive treatment. Usually, it lasts for a week to a couple of weeks.

 

Keeping strict track on your hygiene and your surroundings is often useful if it is recurring. Using humidifiers is also a great way to keep the air around you humid. Taking steam is also often helpful in sinusitis. These steamers could be home-made or market bought dedicated steam developers. This process of inhaling steam vapours can help ease the blocked nose and enable it to breathe again, without many efforts. A hot towel treatment could also be used to reduce the face pressure caused by sinusitis. Using a towel and dipping it into warm water and then putting it on the face can ease the face pressure developed due to sinusitis.

 

Sinusitis Treatment Market Segmentations

According to the market research report the market segment can be categorized into following segments:

 

sinusitis treatment market by segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Disease Treatment:

  • Analgesics
  • Antihistamines
  • Corticosteroids
  • Antibiotics
  • Sulphonamides
  • Quinolones
  • Surgery
  • Others

 

Sinusitis Treatment Market Breakup by Disease Type:

  • Acute Sinusitis
  • Subacute Sinusitis
  • Chronic Sinusitis

 

Market Breakup by Route of Administration:

  • Topical
  • Oral
  • Nasal
  • Injectable

 

Market breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

 

Market breakup by End User:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

 

Sinusitis Treatment Market Breakup by Region:

  • North America
    • United States of America
    • Canada
  • Europe 
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America 
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

sinusitis treatment market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Sinusitis Epidemiology

United States is among the leading regions as it has a high number of sinusitis patients. People suffering for nasal blockages or allergies related to skin or people with asthma and weakened immune systems are at the highest risk of getting and developing sinusitis.

 

People living in places where the transport movement is higher has are also at major risks as the pollutants present in pollution outside are potentially lethal and can cause numerous diseases and disorders related to breathing and lungs, nose. Changing and unhealthy lifestyle is also a major driver for the rise in prevalence of sinusitis globally.

 

Sinusitis Diagnosis

Sinusitis generally does not need to be treated as it goes away on its own. In case the conditions start to go out control, they can be diagnosed by the help of several methods. This will probably happen if the person is having chronic sinusitis. Only after diagnosing, the doctor proceeds further for the treatment of sinusitis. The methods by which sinusitis can be diagnosed are as follows:

 

  • Imaging Tests- CT scans and MRI can show the detailed view of sinuses and affected areas.
  • Sampling of discharges- The samples of the discharges from your nose are collected for further determination of the cause. This sampling is performed when medications stop working or do not respond to the treatment. This can also be done in the case of worsening of sinusitis. Due to all these conditions, doctor collect the samples with the help of a cotton swab for further determination of the existing sinusitis.
  • Skin test- The reason for your sinusitis could be skin allergies as well. Skin test is the best choice when it is about determining the allergen that is responsible for the nasal issues.
  • Endoscopy- An endoscopy could be performed to diagnose the sinusitis. This is done by inserting an endoscope through nose to attain a better vision of the sinus. any deviation or unwanted growth of skin can be detected by the endoscopy.

 

Sinusitis Treatment Landscape

As sinusitis does not need to be treated in most cases, these treatments are for the people who are suffering from chronic sinusitis. There are several treatments that are provided by doctors to treat sinusitis, depending on the requirement of the patients existing condition.

 

  • Antifungal Treatments
  • Nasal Sprays
  • Nasal corticosteroids
  • Oral corticosteroids
  • Injected corticosteroids

 

Common treatments of sinusitis are as follows:

  • Steroid Nasal Sprays
  • Nasal Wash
  • Decongestants
  • Antibiotics
  • Antihistamines
  • Pain Relievers
  • Leukotriene Modifiers

 

Sinusitis Treatment Market Analysis

The market is growing and is expected to grow in coming years as well. The rise in the market is due to various factors, one of which is the exponentially growing pollution globally. Due to the increasing pollution, people are developing sinusitis who have no history with any nasal infections. Acute sinusitis is the most common form of sinusitis affecting people worldwide. Due to the increasing pollution and hectic lifestyles, people usually ignore the common signs of sinus that are similar to having a cold like symptoms. Around 90% of patients having cold, generally have viral sinusitis components. The most common causes of viral sinusitis include polluted air, dust, irritants, viruses, smoke, and bacteria.

 

People with sinusitis are likely to develop other diseases related to breathing as well. Asthma and sinusitis are the conditions that usually exists simultaneously in a patient and are most common. The factors are harmful pollutants that may develop more dangerous conditions which could last for a lifetime.

 

North America contributes to the largest market share of market size due to the high prevalence of increasing pollution, weakened immune system, and increasing nasal inflammation disorders.

 

Competitive Landscape of Sinusitis Treatment Market

The report gives an in-depth analysis of the key players involved in the sinusitis treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

 

  • Pfizer Inc.
  • Merck KGaA
  • Sanofi
  • Biocare Medical LLC
  • Teva Pharmaceutical Industries
  • Bristol-Myers Squibb Company
  • GSK plc
  • Bayer AG
  • AstraZeneca
  • Regeneron Pharmaceuticals Inc.
  • OptiNose US Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment
  • Disease Type
  • Route of Administration
  • End User
  • Distribution Channel
  • Region
Breakup by Treatment
  • Analgesics
  • Antihistamines
  • Corticosteroids
  • Antibiotics
  • Sulphonamides
  • Quinolones
  • Surgery
  • Others
Breakup by Disease Type
  • Acute Sinusitis
  • Subacute Sinusitis
  • Chronic Sinusitis
Breakup by Route of Administration
  • Topical
  • Oral
  • Nasal
  • Injectable
Breakup by End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Merck KGaA
  • Sanofi
  • Biocare Medical, LLC
  • Teva Pharmaceutical Industries
  • Bristol-Myers Squibb Company
  • GSK plc.
  • Bayer AG
  • AstraZeneca
  • Regeneron Pharmaceuticals Inc
  • OptiNose US, Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Sinusitis Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Sinusitis Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Sinusitis Epidemiology (2016-2031)
    5.3    Europe Sinusitis Epidemiology (2016-2031)
    5.4    Asia-Pacific Sinusitis Epidemiology (2016-2031)
    5.5    Latin America Sinusitis Epidemiology (2016-2031)
    5.6    Middle East & Africa Sinusitis Epidemiology (2016-2031)
6    Global Sinusitis Treatment Market Overview
    6.1    Global Sinusitis Treatment Market Historical Value (2017-2023)
    6.2    Global Sinusitis Treatment Market Forecast Value (2024-2032)
7    Global Sinusitis Treatment Market Landscape
    7.1    Sinusitis Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Sinusitis Treatment: Product Landscape
        7.2.1    Analysis by Treatment
        7.2.2    Analysis by Disease Type
        7.2.3    Analysis by Route of Administration
        7.2.4    Analysis by End User
        7.2.5    Analysis by Distribution Channel
8    Sinusitis Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Sinusitis Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends
    10.7    Value Chain Analysis
11    Global Sinusitis Treatment Market Segmentation
    11.1    Global Sinusitis Treatment Market by Treatment
        11.1.1    Market Overview
        11.1.2    Analgesics
        11.1.3    Antihistamines
        11.1.4    Corticosteroids
        11.1.5    Antibiotics
        11.1.6    Sulphonamides
        11.1.7    Quinolones
        11.1.8    Surgery
        11.1.9    Others
    11.2    Global Sinusitis Treatment Market by Disease Type
        11.2.1    Market Overview
        11.2.2    Acute Sinusitis
        11.2.3    Subacute Sinusitis
        11.2.4    Chronic Sinusitis
    11.3    Global Sinusitis Treatment Market by Route of Administration
        11.3.1    Market Overview
        11.3.2    Topical
        11.3.3    Oral
        11.3.4    Nasal
        11.3.5    Injectable
    11.4    Global Sinusitis Treatment Market by End User
        11.4.1    Market Overview
        11.4.2    Hospitals
        11.4.3    Homecare
        11.4.4    Specialty Clinics
        11.4.5    Others
    11.5    Global Sinusitis Treatment Market by Distribution Channel
        11.5.1    Market Overview
        11.5.2    Hospital Pharmacies
        11.5.3    Retail Pharmacies
        11.5.4    Online Pharmacies
    11.6    Global Sinusitis Treatment Market by Region
        11.6.1    Market Overview
        11.6.2    North America
        11.6.3    Europe
        11.6.4    Asia Pacific
        11.6.5    Latin America
        11.6.6    Middle East and Africa
12    North America Sinusitis Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Sinusitis Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Sinusitis Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Sinusitis Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Sinusitis Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Pfizer Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Merck KGaA
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Sanofi
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Biocare Medical, LLC
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Teva Pharmaceutical Industries
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Bristol-Myers Squibb Company
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    GSK plc.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Bayer AG
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    AstraZeneca
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Regeneron Pharmaceuticals Inc
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    OptiNose US, Inc.
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
24    Sinusitis Treatment - Distribution Model (Additional Insight)
    24.1    Overview
    24.2    Potential Distributors
    24.3    Key Parameters for Distribution Partner Assessment
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The treatment market attained a value of USD 3.32 billion in 2023, driven by the rising air pollution.

The sinusitis treatment market is likely to grow at a CAGR of 3.8% during the forecast period of 2024-2032 to attain a value of USD 4.65 billion by 2032.

The major drivers for the market growth include rising pollution, reduced immunity, and asthma.

The treatment methods include analgesics, antihistamines, corticosteroids, antibiotics, sulphonamides, quinolones, and surgery, among others.

Hospitals, home-cares, and specialty clinics, among others are the segments of global sinusitis treatment market.

Market breakup by route of administration is topical, oral, nasal, and injectable.

The major regional markets are North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The key players in the sinusitis treatment market involves Pfizer Inc., Merck KGaA, Sanofi, Biocare Medical LLC, Teva Pharmaceutical Industries, Bristol-Myers Squibb Company, GSK plc, Bayer AG, AstraZeneca, Regeneron Pharmaceuticals Inc., and OptiNose US Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER